Clinical trial

A Trial to Study BAY1753011 in Patients With Congestive Heart Failure

NCT03901729

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-29

PhasePHASE2

Study timeline

Study start (actual)2019-05-29Date precision: day

Registry last updated2022-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure (HF)unresolved

Interventions

BAY 1753011DRUG

Placebo BAY 1753011OTHER

FurosemideDRUG · verified · RxNorm: furosemide

Placebo FurosemideOTHER

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

BudapestHungary3 ValenciaSpain3 SofiaBulgaria3 ViennaAustria2 LisbonPortugal2 ThessalonikiGreece2 MadridSpain1 BarcelonaSpain1 WarsawPoland1 MálagaSpain1 PoznanPoland1 AthensGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03901729 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.